LONDON - The UK government announced a £50 million (US$83 million) program over the next three years to expand the use of genetic testing in the National Health Service (NHS), with the aim of making the UK a leader in genetics-based health care. (BioWorld International)
LONDON - The prospect of a commercial return from the technology that produced Dolly the cloned sheep was effectively killed last week, when Bayer Healthcare LLC announced it was pulling the plug on the development of alpha-1-antitrypsin (AAT), being developed in a US$40 million collaboration with PPL Therapeutics plc. (BioWorld International)
LONDON - The prospect of a commercial return from the technology that produced Dolly the cloned sheep was effectively killed last week, when Bayer Healthcare LLC announced it was pulling the plug on the development of alpha-1-antitrypsin (AAT), being developed in a US$40 million collaboration with PPL Therapeutics plc. (BioWorld International)
